Special features on insulin resistance, metabolic syndrome and vascular complications in hypopituitary patients

Rev Endocr Metab Disord. 2024 Jan 25. doi: 10.1007/s11154-023-09872-8. Online ahead of print.ABSTRACTPituitary hormone deficiency, hypopituitarism, is a dysfunction resulting from numerous etiologies, which can be complete or partial, and is therefore heterogeneous. This heterogeneity makes it difficult to interpret the results of scientific studies with these patients.Adequate treatment of etiologies and up-to-date hormone replacement have improved morbidity and mortality rates in patients with hypopituitarism. As GH replacement is not performed in a reasonable proportion of patients, especially in some countries, it is essential to understand the known consequences of GH replacement in each subgroup of patients with this heterogeneous dysfunction.In this review on hypopituitarism, we will address some particularities regarding insulin resistance, which is no longer common in these patients with hormone replacement therapy based on current guidelines, metabolic syndrome and its relationship with changes in BMI and body composition, and to vascular complications that need to be prevented taking into account the individual characteristics of each case to reduce mortality rates in these patients.PMID:38270844 | DOI:10.1007/s11154-023-09872-8
Source: ENDOCR REV - Category: Endocrinology Authors: Source Type: research